Together, these data define a gut–brain disease axis in CCM, in which microbiota‐derived signals and gut barrier integrity modulate MEKK3–KLF2/4 activation and lesion formation, particularly in the context of PDCD10 deficiency. The gene discussed is MAP3K3; the disease is cerebral cavernous malformation.